Search

everythinglearnresearchcommunity

for

Search:↓

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Dermatologists should customize cosmetic treatments for dark-skinned patients to minimize risks and complications.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Cetuximab can cause unusual hair growth and hair loss.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.